Post-enucleation outcomes of patients with uveal melanoma in Scotland
- 20 October 2022
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 37 (5) , 988-994
Abstract
Background/Objectives To investigate post-enucleation outcomes and assess the effect of extrascleral extension (ESE) on these outcomes for patients with uveal melanoma (UM) managed at a tertiary referral centre in Scotland. Subjects/Methods Retrospective review of all cases of UM managed by the Scottish Ocular Oncology Service for which enucleation was undertaken between 13/03/2008 and 31/12/2020. Primary outcomes were length of survival, time-to-metastasis (TTM) and local recurrence rate. Secondary outcomes were the effects of the presence of ESE, ESE size, and the use of adjuvant external beam radiotherapy (EBRT) on the primary outcomes. Results Of 172 enucleated UMs, 32 (18.6%) had ESE. Over a median follow-up period of 33.7 months (range = 1.1–163.7 months), 91 (52.9%) patients died. The median length of all-cause survival of 54.1 months (range = 1.1–163.7 months). One-year, 5-year, and 10-year survival rates were 84.8%, 49.1%, and 30.9%, respectively. Eighty-four (49.7%) patients had metastatic disease. The median TTM of 42.2 months (range = 0.4–106.8 months). Proportions of patients who developed metastases within 1-year, 5-years and 10-years post-enucleation were 22.7%, 52.8%, and 71.8%, respectively. There was one instance of local orbital recurrence. ESE was associated with a significantly shorter length of survival (p = 0.03). There was a trend towards a shorter length of survival and TTM with ESE > 5 mm and those who received adjuvant EBRT. Conclusions ESE was present in one-sixth of our cohort and was associated with a significantly shorter length of survival, particularly in the presence of ESE > 5 mm or high-risk characteristics warranting adjuvant EBRT. This data will aid prognostication of the patients in our service.Keywords
This publication has 23 references indexed in Scilit:
- Intraocular Tumor-Associated LymphangiogenesisOphthalmology, 2010
- Routes of Extraocular Extension of Uveal MelanomaOphthalmology, 2008
- Incidence of Uveal Melanoma in EuropeOphthalmology, 2007
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal MelanomaArchives of Ophthalmology (1950), 2006
- Incidence of noncutaneous melanomas in the U.S.Cancer, 2005
- Very Long-Term Prognosis of Patients with Malignant Uveal MelanomaInvestigative Ophthalmology & Visual Science, 2003
- Late Orbital Recurrence of a Choroidal Melanoma Following Internal ResectionSurvey of Ophthalmology, 2003
- The COMS randomized trial of iodine 125 brachytherapy for choroidal melanomaOphthalmology, 2002
- The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma, III: Initial Mortality FindingsArchives of Ophthalmology (1950), 2001
- Postenucleation orbital radiotherapy for the treatment of malignant melanoma of the choroid with extrascleral extension.British Journal of Ophthalmology, 1990